Kenneth S Shindler

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 10

Top Topics

Genome Wide Analysis

Top Venues

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

The Journal of biological chemistry

Oxidative medicine and cellular longevity

This page only lists publications with an associated author ORCID identifier.

Publications

Brahim Chaqour, Thu T Duong, Jipeng Yue, Tehui Liu, David Camacho, Kimberly E Dine, Julian Esteve-Rudd, Scott Ellis, Jean Bennett, Kenneth S Shindler, Ahmara G Ross
AAV2 vector optimization for retinal ganglion cell-targeted delivery of therapeutic genes. Gene therapy 31 (3-4) (2024)
Brahim Chaqour, Thu T Duong, Jipeng Yue, Tehui Liu, David Camacho, Kimberly E Dine, Julian Esteve-Rudd, Scott Ellis, Jean Bennett, Kenneth S Shindler, Ahmara G Ross
AAV2 vector optimization for retinal ganglion cell-targeted delivery of therapeutic genes. Gene therapy (2024)
Brahim Chaqour, Thu T Duong, Jipeng Yue, Tehui Liu, David Camacho, Kimberly E Dine, Julian Esteve-Rudd, Scott Ellis, Jean Bennett, Kenneth S Shindler, Ahmara G Ross
AAV2 vector optimization for retinal ganglion cell-targeted delivery of therapeutic genes. Gene therapy 31 (3-4) (2024)
Brahim Chaqour, Thu T Duong, Jipeng Yue, Tehui Liu, David Camacho, Kimberly E Dine, Julian Esteve-Rudd, Scott Ellis, Jean Bennett, Kenneth S Shindler, Ahmara G Ross
AAV2 vector optimization for retinal ganglion cell-targeted delivery of therapeutic genes. Gene therapy 31 (3-4) (2024)
Ehtesham Shamsher, Reas S Khan, Benjamin M Davis, Kimberly Dine, Vy Luong, Satyanarayana Somavarapu, M Francesca Cordeiro, Kenneth S Shindler
Nanoparticles Enhance Solubility and Neuroprotective Effects of Resveratrol in Demyelinating Disease. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics (2023)
Keirnan Willett, Reas S Khan, Kimberly E Dine, Howard Wessel, Ziv Z Kirshner, Jodie L Sauer, Ashley Ellis, Larry R Brown, Kenneth S Shindler
Neuroprotection mediated by ST266 requires full complement of proteins secreted by amnion-derived multipotent progenitor cells. PloS one 16 (1) (2021)
Fareeha Saadi, Debanjana Chakravarty, Saurav Kumar, Mithila Kamble, Bhaskar Saha, Kenneth S Shindler, Jayasri Das Sarma
CD40L protects against mouse hepatitis virus-induced neuroinflammatory demyelination. PLoS pathogens 17 (12) (2021)
Reas S Khan, Ahmara G Ross, Keirnan Willett, Kimberly Dine, Rick Banas, Larry R Brown, Kenneth S Shindler
Amnion-Derived Multipotent Progenitor Cells Suppress Experimental Optic Neuritis and Myelitis. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 18 (1) (2020)
Saurav Saswat Rout, Manmeet Singh, Kenneth S Shindler, Jayasri Das Sarma
One proline deletion in the fusion peptide of neurotropic mouse hepatitis virus (MHV) restricts retrograde axonal transport and neurodegeneration. The Journal of biological chemistry 295 (20) (2020)
Reas S Khan, Kimberly E Dine, John G Geisler, Kenneth S Shindler
Mitochondrial Uncoupler Prodrug of 2,4-Dinitrophenol, MP201, Prevents Neuronal Damage and Preserves Vision in Experimental Optic Neuritis. Oxidative medicine and cellular longevity 2017 (2017)